Preclinical characterization of WAY-211612: a dual 5-HT uptake inhibitor and 5-HT1A receptor antagonist and potential novel antidepressant
AUTOR(ES)
Beyer, CE
FONTE
Blackwell Publishing Ltd
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2697802Documentos Relacionados
- Elevated anxiety and antidepressant-like responses in serotonin 5-HT1A receptor mutant mice
- A brain microdialysis study on 5-HT release in freely moving rat lines selectively bred for differential 5-HT1A receptor function
- Molecular modeling of arylpiperazine compounds and their interactions with the 5-HT1A receptor
- The therapeutic role of 5-HT1A and 5-HT2A receptors in depression
- Structural requirements for 5-HT2A and 5-HT1A serotonin receptor potentiation by the biologically active lipid oleamide